soul trial oral semaglutide cardiovascular outcomes results 2024 nejm New Science Suggests Semaglutide Improves CV Outcomes Beyond Weight Loss Trial Scorecard: SOUL

Diabetes medications and cancer risk associations: a systematic review and meta-analysis of evidence over the past 10 years

From our own study, more than 1 in 2 participants experienced better bowel movements after taking GLH-2

Manufacturers initially followed the standard playbook: maintain high retail prices (paid by almost no one) while offering modest discounts to Medicare and insurers

Zhu Y, Jameson E, Crosatti M, Schfer H, Rajakumar K, Bugg TD, Chen Y: Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota

You actually inject 5.0 mg

Anti-Ferroptotic effects of bone marrow mesenchymal stem Cell-Derived extracellular vesicles loaded with Ferrostatin-1 in cerebral ischemia-reperfusion injury associate with the GPX4/COX-2 Axis